Evaluation of anticancer medicinal products in man

The proposed guideline will replace 'guideline on the evaluation of anticancer medicinal products in man' (EMA/CHMP/205/95 Rev.5)

Keywords: Cancer, malignancy, biomarker, targeted drugs, pharmacogenomics

Document history

Topics

How useful was this page?

Add your rating
Average
1 rating